{"id":47777,"date":"2022-08-29T23:01:51","date_gmt":"2022-08-29T21:01:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/"},"modified":"2022-08-29T23:01:51","modified_gmt":"2022-08-29T21:01:51","slug":"goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/","title":{"rendered":"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference"},"content":{"rendered":"
\n

SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA on Thursday, September 15, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time).\n<\/p>\n

<\/a><\/p>\n

\nA live webcast of the presentation will be available on the Company’s Investor Relations website, https:\/\/investors.goodrx.com\/<\/a>. Following the conference, an archived recording will be available on the Company\u2019s website for at least 30 days.\n<\/p>\n

\nAbout GoodRx<\/b>\n<\/p>\n

\nGoodRx is a leading consumer-focused digital healthcare platform. Our technology delivers strong savings, trusted information and access to care to make healthcare affordable and convenient for all Americans. Since 2011, we have helped consumers save over $40 billion and are one of the most downloaded medical apps over the past decade.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact<\/b>
GoodRx
\n
Whitney Notaro
\n
wnotaro@goodrx.com<\/a>\n<\/p>\n

\nPress Contact<\/b>
GoodRx
\n
Lauren Casparis
\n
lcasparis@goodrx.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA on Thursday, September 15, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time). A live webcast of the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47777","6":"format-standard","7":"category-industry"},"yoast_head":"\nGoodRx to Present at the Goldman Sachs Communacopia + Technology Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA on Thursday, September 15, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time). A live webcast of the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-29T21:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220829005560\/en\/1555580\/21\/GoodRx_logo_New.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference\",\"datePublished\":\"2022-08-29T21:01:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/\"},\"wordCount\":166,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005560\\\/en\\\/1555580\\\/21\\\/GoodRx_logo_New.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/\",\"name\":\"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005560\\\/en\\\/1555580\\\/21\\\/GoodRx_logo_New.jpg\",\"datePublished\":\"2022-08-29T21:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005560\\\/en\\\/1555580\\\/21\\\/GoodRx_logo_New.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005560\\\/en\\\/1555580\\\/21\\\/GoodRx_logo_New.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/","og_locale":"en_US","og_type":"article","og_title":"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference - Pharma Trend","og_description":"SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA on Thursday, September 15, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time). A live webcast of the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-29T21:01:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220829005560\/en\/1555580\/21\/GoodRx_logo_New.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference","datePublished":"2022-08-29T21:01:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/"},"wordCount":166,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005560\/en\/1555580\/21\/GoodRx_logo_New.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/","url":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/","name":"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005560\/en\/1555580\/21\/GoodRx_logo_New.jpg","datePublished":"2022-08-29T21:01:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220829005560\/en\/1555580\/21\/GoodRx_logo_New.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220829005560\/en\/1555580\/21\/GoodRx_logo_New.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/goodrx-to-present-at-the-goldman-sachs-communacopia-technology-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47777"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47777\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}